about
Shiga toxin receptor Gb3Cer/CD77: tumor-association and promising therapeutic target in pancreas and colon cancerThe Human Cathelicidin Antimicrobial Peptide LL-37 and Mimics are Potential Anticancer DrugsSeparation of sodiated isobaric disaccharides and trisaccharides using electrospray ionization-atmospheric pressure ion mobility-time of flight mass spectrometry.Sparse canonical methods for biological data integration: application to a cross-platform study.Differences in CD75s- and iso-CD75s-ganglioside content and altered mRNA expression of sialyltransferases ST6GAL1 and ST3GAL6 in human hepatocellular carcinomas and nontumoral liver tissues.Antibody recognition of cancer-related gangliosides and their mimics investigated using in silico site mapping.Racotumomab-alum vaccine for the treatment of non-small-cell lung cancer.Cancer vaccines and carbohydrate epitopes.Alteration of Electrostatic Surface Potential Enhances Affinity and Tumor Killing Properties of Anti-ganglioside GD2 Monoclonal Antibody hu3F8Anti-ganglioside anti-idiotypic vaccination: more than molecular mimicry.Tumors: too sweet to remember?Glycan antagonists and inhibitors: a fount for drug discovery.Affinity-matured recombinant immunotoxin targeting gangliosides 3'-isoLM1 and 3',6'-isoLD1 on malignant gliomas.Sialic acid as a potential approach for the protection and targeting of nanocarriers.Antigen-specific versus antigen-nonspecific immunotherapeutic approaches for human melanoma: the need for integration for optimal efficacy?Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesionsAnti-NeuGcGM3 reactivity: a possible role of natural antibodies and B-1 cells in tumor immunosurveillance.Ganglioside GD3 enhances adhesion signals and augments malignant properties of melanoma cells by recruiting integrins to glycolipid-enriched microdomains.Onconase cytotoxicity relies on the distribution of its positive charge.Detection of Naturally Occurring Human Antibodies Against Gangliosides by ELISA.Natural, synthetic and semisynthetic glycolipid inhibitors of glioma growth.Recombinant Immunotoxin Therapy of Glioblastoma: Smart Design, Key Findings, and Specific Challenges.Human gliosarcoma-associated ganglioside composition is complex and distinctive as evidenced by high-performance mass spectrometric determination and structural characterization.Generation and characterization of a IgG monoclonal antibody specific for GM3 (NeuGc) ganglioside by immunizing β3Gn-T5 knockout mice.Focused microarray analysis of glyco-gene expression in human glioblastomas.Vaccine and immune cell therapy in non-small cell lung cancer.Biochemical, pathological and oncological relevance of Gb3Cer receptor
P2860
Q21090050-30E7FAEC-8521-49A1-BDAD-AB763DB238F1Q26801532-42E2F273-003E-4AAD-BD14-CE8151E1A29EQ31165937-3BA002F5-BEE1-4644-8303-E889B22F9219Q33403099-EE22F5F4-1979-4E7F-9E10-AB931B803C2BQ33767713-64AE7BB9-85DF-4692-89A5-8990D7CF0424Q34247281-015EB339-FD86-4D16-B086-3503D467AC24Q34449304-31DFAFFE-C7A6-44B1-9EB4-30EBDAA96E07Q35525289-0DF28A67-99B2-4456-AF4A-710AF95238DAQ35860917-4BB35B76-0A4A-4C4F-BCC0-463707D2CE28Q36410563-4AE20E6F-75DE-40EE-833B-BE057BD8C382Q37021511-D6689AEA-6F61-446A-8D4A-E272A5C5B83DQ37027396-F3EE766F-2109-4B6E-942D-D2CC732F11F2Q37364358-E548D1A4-6E27-4AA6-989C-B05E17C0CD1BQ37867700-7FA9B28D-43F7-435A-84CA-0AF726688F41Q37952804-83B18E33-55A9-4F5F-A5CD-6C41A2912C1CQ38784095-E626436C-E580-4EFA-BAAB-A726DDC9D579Q38848896-B9B75843-48E7-401D-8EC6-453D4A16CBF6Q39687825-24F3EE8B-5FE9-4B48-B6C0-0293D035995EQ39838747-AE299F41-A972-4842-B5EF-42350E45614AQ40151254-61E713DB-3E17-4DA6-B005-D795A0E39CC6Q40521243-70D46890-2889-4159-B1C8-B2EB0EEAA681Q41022992-2DE89134-7945-49D3-A86F-2D4063F1EF5FQ48276171-B04FB57B-C941-48CA-A793-C9CEAED7A4EBQ50129835-8A066DE5-15D4-4ABF-B52B-4702C0509657Q50852489-CB6F1336-5DAD-4EE1-A78F-6DEBC6304122Q55284807-1F4AF3D0-AF33-468E-9045-EC4A4BB534CBQ57117659-3803DE56-42B3-4829-9901-0BC5F8F31BF7
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Gangliosides as therapeutic targets for cancer.
@ast
Gangliosides as therapeutic targets for cancer.
@en
type
label
Gangliosides as therapeutic targets for cancer.
@ast
Gangliosides as therapeutic targets for cancer.
@en
prefLabel
Gangliosides as therapeutic targets for cancer.
@ast
Gangliosides as therapeutic targets for cancer.
@en
P2093
P1433
P1476
Gangliosides as therapeutic targets for cancer.
@en
P2093
Kristina Hedberg
Pam Fredman
Thomas Brezicka
P304
P356
10.2165/00063030-200317030-00002
P577
2003-01-01T00:00:00Z
P6179
1034972098